Fundz

Who to call at QIAGEN, and when

Fundz watches for the moments QIAGEN starts buying, and tells you who to reach.

  • An alert the day QIAGEN raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at QIAGEN, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

QIAGEN and EQT Private Equity Enter Agreement for All-Cash Takeover Offer at €46.50 per Share

Oct 22, 2026

Contract Type

agreement

BiotechnologyHealth CareScience And EngineeringInternet Services

Description

QIAGEN and EQT Private Equity have agreed on a public takeover offer for QIAGEN shares at €46.50 each, representing a 40.3% premium. The transaction is fully supported by QIAGEN's board and is expected to close in mid-2027, pending regulatory approvals.

Company Information

Company

QIAGEN

About

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in molecular diagnostics (human healthcare), Applied Testing (primarily forensics), Pharma (pharma and biotech companies) and Academia (life sciences research). As of March 31, 2022, QIAGEN employed more than 6,000 people in over 35 locations worldwide. Further information can be found at www.qiagen.com.

Predictive Intelligence
Strategic

ML-powered predictions for QIAGEN's next move

Learn about Strategic plan

QIAGEN signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.